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In response to antigenic stimulation B cells undergo class switch recombination (CSR) 
at the immunoglobulin heavy chain (IgH) to replace the primary IgM/IgD isotypes by 
IgG, IgE, or IgA. CSR is initiated by activation-induced cytidine deaminase (AID) through 
the deamination of cytosine residues at the switch (S) regions of IgH. B cell stimulation 
promotes germline transcription (GLT) of specific S regions, a necessary event prior 
to CSR because it facilitates AID access to S regions. Here, we show that CCCTC-
binding factor (CTCF)-deficient mice are severely impaired in the generation of germinal 
center B cells and plasma cells after immunization in vivo, most likely due to impaired 
cell survival. Importantly, we find that CTCF-deficient B cells have an increased rate 
of CSR under various stimulation conditions in vitro. This effect is not secondary to 
altered cell proliferation or AID expression in CTCF-deficient cells. Instead, we find 
that CTCF-deficient B cells harbor an increased mutation frequency at switch regions, 
probably reflecting an increased accessibility of AID to IgH in the absence of CTCF. 
Moreover, CTCF deficiency triggers premature GLT of S regions in naïve B cells. Our 
results indicate that CTCF restricts CSR by enforcing GLT silencing and limiting AID 
access to IgH.
Keywords: class switch recombination, cccTc-binding factor, germline transcription, activation-induced 
deaminase, somatic hypermutation
inTrODUcTiOn
B cells remodel their immunoglobulin genes first as part of their differentiation program in the 
bone marrow, and then during the immune response, in the context of germinal centers (1). In 
the bone marrow, the heavy (IgH) and the light chain (IgL) immunoglobulin genes are subject 
to V(D)J recombination, a site specific recombination reaction triggered by RAG recombinases 
(2, 3). Subsequently, B cells that have been activated by antigen engage in the germinal center 
reaction where immunoglobulin genes are further diversified by somatic hypermutation (SHM) 
and class switch recombination (CSR), both of which are initiated by the activation-induced 
cytidine deaminase (AID) enzyme (4–6). SHM introduces (mostly) point mutations in the 
antigen recognizing, variable region of the IgH and IgL genes and antibody variants with higher 
affinity for antigen are selected through iterative rounds of mutation, proliferation, and cell death 
(7). CSR is a region-specific recombination reaction whereby the primary μ constant region 
(Cμ) is replaced by a downstream constant region (Cγ, Cε, or Cα) in the IgH gene, such that 
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the primary IgM/IgD isotypes switch to IgG, IgE, or IgA (8, 9). 
Highly repetitive sequences called switch (S) regions preceding 
each constant region are targeted by AID, which triggers the 
deamination of cytosines followed by the generation of double 
strand breaks and the recombination reaction. CSR to a par-
ticular isotype is determined by stimulation-driven cues that 
activate specific S region I promoters, inducing their germline 
transcription (GLT) (10). GLT of both the donor and acceptor 
S regions is an absolute requirement for CSR, presumably by 
promoting transcription-coupled AID recruitment (11).
Both V(D)J recombination and CSR are tightly develop-
mentally regulated, are intimately linked to transcription, and 
involve the formation of long-range DNA loops that facilitate 
the interaction between distant cis regulatory regions. CCCTC-
binding factor (CTCF) is an architectural protein that regulates 
the genome function by mediating interactions between distant 
DNA sequences (12, 13) and is known to act as a transcriptional 
insulator through the generation of chromatin loops (14–16). 
CTCF regulates bone marrow B  cell differentiation at differ-
ent levels. First, CTCF-deficient pre-B  cells show impaired 
proliferation and differentiation (17). Further, CTCF mediates 
interactions between distal and proximal regions of the IgH 
locus, regulating its transcription (18), and CTCF-binding ele-
ments (CBEs) are critical to inhibit rearrangement of proximal 
VH genes and promoting rearrangement of distal VH genes 
(19, 20). Finally, IgH employs CBE-based subdomains to regulate 
RAG on- and off-target activity (21). Regarding the role of CTCF 
during the germinal center reaction, we have recently shown that 
CTCF is an essential transcriptional regulator that allows high 
proliferation rate of germinal center B  cells and represses the 
expression of Blimp-1, thus preventing plasma cell differentia-
tion (22). However, the role of CTCF in CSR is not completely 
understood. The IgH locus is flanked by a 3′ regulatory region 
(3′RR), located 3′ of the most downstream CH, the Cα gene 
(23, 24). The proximal 3′RR contains several B  cell-specific 
enhancers (hs3a, hs1,2, hs3b, and hs4) that are required for IgH 
GLT, class switching to all isotypes and high levels of Ig transcrip-
tion in plasma cells (25–27). The distal 3′RR enhancer region 
(containing hs5, 6, 7, and 38 enhancers) is densely riveted with 
CBEs, and deletion of hs5–7 (harboring seven of the nine CBEs 
at the distal 3′RR) affected IgH locus compaction and VH usage 
during V(D)J recombination, but did not affect CSR (28). In con-
trast, a CBE has been very recently identified within the Cα gene 
whose deletion promotes isotype-specific GLT in developing and 
resting B cells and alters CSR (29).
Here, we have directly assessed the role of CTCF in CSR using 
a conditional mouse model for CTCF depletion in B  cells. We 
find that CTCF-deficient B cells show increased rate of CSR to 
various isotypes and under various stimulation conditions. This 
effect was not related to any measurable alterations of cell cycle 
or proliferation and was not a consequence of increased levels 
of AID expression. Instead, we find that AID activity is quan-
titatively increased on S regions. Finally, we show that GLT is 
markedly increased from activation-inducible, acceptor S regions 
in CTCF-deficient naïve B cells, indicating that CTCF restricts 
the transcription of activation-inducible S regions and limits AID 
accessibility and CSR.
MaTerials anD MeThODs
Mice and immunization
CCCTC-binding factor-deficient mice were obtained by breed-
ing CTCFfl/fl mice (30) with CD19-Creki/+ (31) mice. In all the 
experiments, CTCFfl/+; CD19-Creki/+ littermates were used as 
controls. Both males and females were used for experiments. 
All animals were housed in specific pathogen-free conditions, 
under a 12 h dark/light cycle with food ad  libitum. All animal 
procedures were conducted according to EU Directive 2010/63/
UE, enforced in Spanish law under Real Decreto 53/2013. The 
procedures have been reviewed by the Institutional Animal 
Care and Use Committee (IACUC) of Centro Nacional de 
Investigaciones Cardiovasculares and approved by Consejeria 
de Medio Ambiente, Administración Local y Ordenación del 
Territorio of Comunidad de Madrid (Ref: PROEX 341/14).
T-dependent immunization was induced in 6–11  weeks 
CTCFfl/fl; CD19-Creki/+ or CTCFfl/+; CD19-Creki/+ mice by intra-
venously injection of 108 sheep red blood cells resuspended in 
100  µl of sterile PBS. Immunization response was analyzed in 
spleen 7  days after sheep red blood cell injection. Number of 
animals per group to detect biologically significant effect sizes 
was calculated using appropriate statistical sample size formula 
and indicated in the biometrical planning section of the animal 
license submitted to the governing authority.
cell cultures
Primary B cells from CTCFfl/fl; CD19-Creki/+ or CTCFfl/+; CD19-
Creki/+ mice were isolated from spleen by immunomagnetic 
depletion using anti-CD43 beads (Miltenyi Biotec). Purified 
B cells were cultured at a final concentration of 1.2 × 106 cell/
ml in complete RPMI supplemented with 10% of FBS, 50 mM 
of 2-βmercaptoethanol (Gibco), 20  mM Hepes (Gibco) and 
10  ng/ml of IL-4 (PeproTech) and 25  µg/ml of lipopolysac-
charide (LPS, Sigma-Aldrich) or 1 µg/ml of anti-mouse CD40 
(BD Pharmingen) and 10 ng/ml of IL-4 (PeproTech) to switch 
to IgG1; 25  µg/ml of LPS (Sigma-Aldrich) to switch to IgG3; 
20 ng/ml of TGF-β (RD Systems), 1 µg/ml of anti-mouse CD40 
(BD Pharmingen), and 10 ng/ml of IL-4 (PeproTech) to switch 
to IgG2b.
Flow cytometry
Single-cell suspensions were obtained from spleen or cultured 
B cells and stained with fluorophore-conjugated anti-mouse or 
human antibodies (BD Pharmingen or Invitrogen) to detect B220 
(RA3-6B2, 1/200), Fas (Jo2, 1/400), GL7 (1/200), CD138 (281-2, 
1/200), immunoglobulin G1 (IgG1, A85-1, 1/400), immuno-
globulin G3 (IgG3, R40-82, 1/200), and immunoglobulin G2b 
(IgG2b, RMG2b-1, 1/200). Cell death was assessed by Annexin 
V (BD Pharmingen) staining. DNA incorporation was measured 
by BrdU staining (FITC BrdU Flow Kit, BD Pharmingen). 
Proliferation was assessed by cell trace CFSE staining (Invitrogen). 
Proliferation index was calculated as total number of divisions 
that took place in the culture divided by number of cells that have 
undergone at least one cell division. Samples were acquired on 
LSRFortessa or FACSCanto instruments (BD Biosciences) and 
analyzed with FlowJo Software.
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next-generation sequencing
Analysis of Sμ mutations was performed as previously described 
(32). Briefly, DNA was extracted from LPS/IL-4 stimulated B cells 
from CTCFfl/fl; CD19-Creki/+ (n =  3) or CTCFfl/+; CD19-Creki/+ 
(n = 3) mice. Sμ fragment was PCR amplified using the oligo-
nucleotides (forward) 5′-AAT GGA TAC CTC AGT GGT TTT 
TAA TGG TGG GTT TA-3′ and (reverse) 5′-GCG GCC CGG 
CTC ATT CCA GTT CAT TAC AG-3′. Amplification reactions 
were carried out with 2.5 U of Pfu Ultra (Stratagene) in a 50-μl 
reaction with the following profile: 94°C for 5 min followed by 
25 cycles at 94°C for 10  s, 60°C for 30  s, and 72°C for 1  min. 
PCR products from four independent reactions per mouse were 
pooled and NGS sequencing was performed by the Genomics 
Unit at CNIC. Briefly, Libraries were prepared using NEBNext 
Ultra DNA Library Prep (New England Biolabs) following manu-
facturer’s instructions and sequenced on a HiSeq2500 (Illumina).
qrT-Pcr
RNA was extracted from CTCFfl/fl; CD19-Creki/+ or CTCFfl/+; 
CD19-Creki/+ mice using the Qiagen RNeasy kit and treated with 
DNAse. cDNA was synthesized using random hexamers (Roche) 
and SuperScript II reverse transcriptase. cDNA was quantified 
by SYBR green assay (Applied Biosystems) and normalized to 
GAPDH expression in duplicates. The following primers were 
used: mouse-GAPDH (forward) 5′-TGA AGC AGG CAT CTG 
AGG G-3′ (reverse) 5′-CGA AGG TGG AAG AGT GGG AG-3′; 
mouse-CTCF (forward) 5′-CAC CTG GGT CCT AAC AGA 
ACA GA-3′; mouse-CTCF (reverse) 5′-AGT ATG AGA GCG 
AAT GTG TCG TTT-3′, GLT-G1 (forward) 5′-TCG AGA AGC 
CTG AGG AAT GTG-3′; GLT-G1 (reverse) 5′-ATG GAG TTA 
GTT TGG GCA GCA-3′; GLT-G3 (forward) 5′-AGA GTC AGC 
CTC AAG GAG ATG AT-3′; GLT-G3 (reverse) 5′-CAG GGA 
CCA AGG GAT AGA CAG-3′, GLT-G2b (forward) 5′-CCA ACC 
AGG AAG AGT CCA GAG-3′; GLT-G3b (reverse) 5′-ACA GGG 
ATC CAG AGT TCC AAG T-3′; mouse-AID (forward) 5′-ACC 
TTC GCA ACA AGT CTG GCT-3′, mouse-AID (reverse) 5′-
AGC CTT GCG GTC TTC ACA GAA-3′.
immunoblotting
B cells from LPS/IL-4 cultures were incubated on ice for 20 min in 
RIPA lysis buffer in the presence of protease inhibitors (Roche), 
and lysates were cleared by centrifugation. Total protein was size-
fractionated on SDS-PAGE 12% acrylamide–bisacrylamide gels 
and transferred to Protran nitrocellulose membrane (Whatman) 
in transfer buffer (0.19 M glycine, 25 mM Tris base, and 0.01% 
SDS) containing 20% methanol (90 min at 0.4 A). Membranes 
were probed with anti-mouse-AID (1/25, eBioscience, 
14-5959-82) and anti-mouse-MEK2 (1/2,000, BD Biosciences 
Pharmingen, 610,236). Then, membranes were incubated with 
HRP-conjugated anti-rat (1/5,000, Bethyl Laboratories, A110-
105P) and anti-mouse (1/10,000, DAKO) antibodies, respectively, 
and developed with Clarity™ Western ECL Substrate (Bio-Rad).
statistics
Statistical analyses were performed with GraphPad Prism 
(version 6.01 for Windows, GraphPad Software, San Diego, 
CA, USA) using two-tailed Student’s t-test for all parameters 
conforming to normal distributions (according to Shapiro–Wilk 
normality test). Variance similarity was assessed with F test. 
p ≤  0.05 was considered statistically significant. Error bars in 
figures represent SD.
resUlTs
To address the function of CTCF during CSR we generated 
a conditional mouse model to deplete CTCF late during B cell 
differentiation. CTCFfl/fl mice (30) were bred to CD19-Creki/+, 
where the Cre recombinase is progressively expressed in the bone 
marrow and allows full depletion of floxed alleles at late stages of 
B cell differentiation (31). CTCFfl/fl; CD19-Creki/+ (CTCF-deficient 
mice, hereafter CTCFfl/fl) and CTCFfl/+; CD19-Creki/+ littermates 
(control mice, hereafter CTCFfl/+) were used in all experiments, 
since we have previously shown that CTCF is not haploinsufficient 
in mature B cells (22). We first analyzed the effect of CTCF deple-
tion in Peyer’s patches, where germinal centers are constitutively 
generated in response to antigens of the gut microbiota, and found 
that CTCFfl/fl Peyer’s patches are almost completely devoid of 
germinal center B cells (Figure 1A). To analyze the role of CTCF 
in de novo germinal center formation, we immunized CTCFfl/fl 
and CTCFfl/+ mice with sheep red blood cells and analyzed spleen 
populations by flow cytometry 7  days after immunization. We 
found that both Fas+GL7+ germinal center B cells and CD138+ 
plasma cells were virtually absent in CTCFfl/fl mice (Figure 1B), 
further indicating that CTCF is absolutely required for germinal 
center formation, and concomitantly, for plasma cell generation. 
In vitro stimulation of spleen B cells in the presence of LPS and 
IL-4 revealed that CTCFfl/fl cells had a major B cell survival defect 
as measured by Annexin V staining (Figure 1C) and by viability 
stain exclusion (Figure  1D). Thus, these results suggest that 
CTCF is required for germinal center formation at least in part by 
enabling B cell survival.
We have previously generated a conditional mouse model 
where CTCF depletion is induced only upon AID expression 
[CTCFfl/fl; AID-CreTG/+ mice (22)], i.e., delayed in comparison with 
the model presented here, where naïve B cells are already devoid 
of CTCF (Figure  1E). Consistently with the findings reported 
here, in CTCFfl/fl; AID-CreTG/+ mice CTCF is also essential for 
the germinal center reaction (22). In contrast, B  cells from the 
AID-Cre and the CD19-Cre models widely differ in their response 
to in vitro stimulation: while CTCF depletion in CTCFfl/fl; AID-
CreTG/+ B cells did not lead to any measurable defect upon CSR 
stimulation by LPS + IL-4 (22), CTCFfl/fl; CD19-Creki/+ B cells dis-
play a clear survival defect. Besides the functional implications of 
this disparity (discussed below), the CTCFfl/fl; CD19-Creki/+ model 
opens the possibility to study the function of CTCF in CSR, which 
could not be accurately addressed in CTCFfl/fl; AID-CreTG/+ mice.
To assess the role of CTCF in CSR we stimulated spleen B cells 
from CTCFfl/fl and CTCFfl/+ mice in vitro in the presence of LPS 
and IL-4 and measured CSR to IgG1 by flow cytometry analysis. 
We found that CTCF-deficient cells consistently showed increased 
rate of CSR at all analyzed time points (Figures 2A,B). To deter-
mine whether the enhancement of CSR in CTCF-deficient cells 
was restricted to the IgG1 isotype or to the specific conditions 
of LPS + IL-4 stimulation, we stimulated CTCFfl/fl and CTCFfl/+ 
FigUre 1 | CCCTC-binding factor (CTCF) is required for the germinal center reaction in CTCFfl/fl; CD19-Creki/+ mice. (a) Flow cytometry analysis of Fas and GL7 
expression in Peyer’s patch B cells from CTCFfl/+ (n = 4) and CTCFfl/fl (n = 4) mice. Representative B220+ gated plots are shown on the left. Quantifications are 
shown on the right as percentage within B220+ cells. Each dot represents an individual mouse. p(Fas/GL7) = 0.01. (B) Flow cytometry analysis of GL7, Fas (top) 
and CD138, B220 (bottom) expression in splenic B cells from CTCFfl/+ (n = 4) and CTCFfl/fl (n = 5) mice 7 days after SRBC immunization. Plots are gated on B220+ 
cells (top) or on total alive cells (bottom). Quantifications are shown on the right. Each dot represents an individual mouse. p(Fas/GL7) = 0.0006; p(B220/
CD138) < 0.0001. (c) Annexin V staining in CTCFfl/+ (n = 2) and CTCFfl/fl (n = 2) after 72 h of lipopolysaccharide (LPS) + IL-4 stimulation. A representative flow 
cytometry histogram is shown. Numbers indicate percentages ± SD. (D) Quantification of viable cells (7-AAD−) by flow cytometry analysis in CTCFfl/+ (n = 15) and 
CTCFfl/fl (n = 14) after LPS + IL-4 stimulation; p(24 h) < 0.0001; p(48 h) < 0.0001. Each point corresponds to B cell cultures from an individual mouse. (e) qRT-PCR 
analysis of CTCF expression in resting and activated B cells from CTCFfl/+ (n = 7) and CTCFfl/fl (n = 8) mice. p(0 h) = 0.0009; p(48 h) < 0.0001. Statistical analysis 
was done with two-tailed unpaired Student’s t-test.
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B cells with anti-CD40 + IL-4, LPS, or TGFβ + anti-CD40 + IL-4, 
which preferentially trigger the activation of Iγ1, Iγ3, and Iγ2b 
S region promoters and the switch to IgG1, IgG3, and IgG2b, 
respectively. All three stimulations resulted in a notable increase 
in CSR in CTCFfl/fl cells, indicating that CTCF deficiency broadly 
enhances the rate of CSR, regardless of the activation stimulus or 
the particular S region being used in the recombination reaction 
(Figure 2C). Thus, our results indicate that CTCF restricts the 
extent of CSR during B cell activation.
Class switch recombination is tightly associated with prolif-
eration (9, 33), such that B  cells that have undergone more cell 
divisions accumulate a bigger fraction of isotype-switched cells. To 
FigUre 2 | CCCTC-binding factor (CTCF) deficiency increases the rate of class switch recombination (CSR) in vitro. (a) Representative flow cytometry analysis of 
surface IgG1 expression 1 in splenic B cells from CTCFfl/+ and CTCFfl/fl mice after 48 h (top panels) and 72 h (bottom panels) of lipopolysaccharide (LPS) + IL-4 
stimulation. (B) Quantification of IgG1 cells in CTCFfl/+ (n = 12) and CTCFfl/fl (n = 11) B cells. Each dot corresponds to a B cell culture from an individual mouse. Time 
of analysis is indicated underneath. Mean values are indicated in horizontal. p(48 h) < 0.0001; p(72 h) < 0.0001; p(96 h) = 0.0119. (c). Representative flow 
cytometry analysis (top) of surface expression of CSR in splenic B cells from CTCFfl/+ (n = 4) and CTCFfl/fl (n = 4) mice after 72 h of anti-CD40 + IL-4 (left), LPS 
(middle), and TGFβ + anti-CD40 + IL-4 (right) stimulation. Quantification of IgG 48 and 72 h after stimulation is shown on the bottom. p(anti-CD40 + IL-4) = 0.0022; 
p(LPS) = 0.0021; p(TGFβ + anti-CD40 + IL-4) = 0.033. Statistical analysis was done with two-tailed unpaired Student’s t-test.
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investigate whether the increased rate of CSR could be secondary 
to an alteration in cell proliferation, we first performed cell cycle 
analysis of CTCFfl/fl and CTCFfl/+ B cells stimulated with LPS + IL-4. 
We could not detect any alteration in the proportion of cells in G1, 
S, or G2/M as measured by BrdU incorporation (Figure 3A). The 
rate of cell proliferation analyzed by CFSE dilution and the pro-
liferation index were also indistinguishable between CTCFfl/fl and 
CTCFfl/+ LPS + IL-4 stimulated B cells (Figures 3B,C). Further, we 
measured the rate of CSR to IgG1 as a function of the number of 
cell divisions, and we found that CTCFfl/fl cells display an enhanced 
CSR frequency compared to CFCFfl/+ cells, regardless of the 
number of divisions they have undergone (Figure 3D). Together, 
these observations indicate that the increased CSR rate observed 
in CTCF-deficient B cells is not a collateral effect of cell prolifera-
tion alterations and instead it suggests that it could be intrinsically 
related to the molecular mechanism of CSR.
Activation-induced cytidine deaminase initiates CSR by 
deaminating cytosines on the IgH S regions, and AID levels 
roughly correlate with the efficiency of CSR (34). To address 
whether CTCF regulates the expression of AID during B  cell 
activation, CTCFfl/fl and CTCFfl/+ B  cells were stimulated with 
LPS  +  IL-4, and AID levels were assessed by qRT-PCR and 
FigUre 3 | CCCTC-binding factor (CTCF) deficiency does not affect cell proliferation. (a) Cell cycle analysis of spleen B cells from CTCFfl/+ (n = 4) and CTCFfl/fl 
(n = 4) mice 48 h after lipopolysaccharide (LPS) + IL-4 stimulation. DNA content was analyzed by flow cytometry after BrdU incorporation (30 min pulse) and 7-AAD 
staining. Representative plots are shown. Quantification of G1, S, and G2/M phase proportions is shown on the right. (B) CFSE staining of spleen B cells from 
CTCFfl/+ and CTCFfl/fl mice 72 h after LPS + IL-4 stimulation. (c) Proliferation index of spleen B cells from CTCFfl/+ (n = 15) and CTCFfl/fl (n = 14) mice 72 h after 
LPS + IL-4 stimulation measured by CFSE. (D) Percentage of IgG1 expression on each cell division measured by CFSE 72 h after LPS + IL-4 stimulation. p(0 
division) = 0.0055; p(1 division) = 0.0298; p(2 division) = 0.0048; p(3 division) = 0.005. Numbers indicate percentages ± SD. Statistical analysis was done by 
two-tailed unpaired Student’s t-test.
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western blot analysis. We found that CTCF deficiency did not 
significantly affect the expression of AID at the mRNA or protein 
level (Figures 4A,B).
A fraction of AID-induced deaminations on S regions are 
processed into DNA double strand breaks, while others give 
rise to mutations that can be used to track AID activity (33, 
35–37). Thus, we next compared the mutation frequency in 
Sμ of CTCFfl/fl and CTCFfl/+ B cells stimulated with LPS +  IL-4 
by PCR-Seq (32). We found that Sμ regions of CTCFfl/fl B cells 
accumulated a significantly higher frequency of mutations 
than CTCFfl/+ B  cells (Figure  4C). In both CTCF-proficient 
and -deficient B cells, mutations clustered preferentially at WRCY/
RGYW AID mutational hotspots (38) (Figure 4C) and extended 
throughout the length of the sequenced region (Figure 4D; Table 
S1 in Supplementary Material). These findings indicate that 
AID-induced mutation frequency at S regions is quantitatively 
increased in CTCFfl/fl B  cells, suggesting that CTCF deficiency 
could enhance AID activity by facilitating its access to S regions 
at IgH. In agreement with this idea, we found that the density of 
CTCF-binding to the different CBEs interspersed at the IgH locus 
was altered in LPS/IL-4 stimulated B cells as compared with naïve 
B cells (39) (Figure 4E). Specifically, we found that several CBEs, 
such as the 5′hs1R1 site (29, 39), and peaks 3 and 7 at the 3′RR 
(Figure 4E) were more densely bound by CTCF in resting than 
in activated B cells, while we found no difference or the reverse 
trend for other CBEs. This analysis indicates that during B cell 
activation, binding of CTCF to the IgH is rearranged, suggesting 
that CTCF could be an important factor involved in chromatin 
remodeling of IgH during B cell activation.
To gain further insights into the role in CTCF in regulating IgH 
accessibility, we measured GLT at donor and acceptor S regions 
in CTCF-proficient and -deficient B  cells. GLT is absolutely 
required for CSR and is widely considered an indicator of S region 
accessibility (10, 11). While Sμ is transcribed constitutively, GLT 
at acceptor S regions is induced only upon appropriate stimula-
tion of I promoters. We measured GLT at S regions in naïve and 
stimulated B cells and found that Sμ transcription was not affected 
in CTCFfl/fl B cells compared to CTCFfl/+ B cells, regardless of their 
resting or activated state (Figure 5A). In contrast, GLT expression 
of Sγ1 acceptor region was significantly increased in naïve B cells, 
but not in activated B cells (Figure 5B). Accordingly, GLT-γ3 and 
GLT-γ2b also showed a clear increase in CTCFfl/fl naïve B cells 
when compared to CTCFfl/+ B cells (Figure 5C). Together, these 
results show that CTCF prevents GLT of S regions prior to B cell 
activation, and that CTCF deficiency unleashes transcription 
from the I promoters in naïve B cells.
DiscUssiOn
In this work, we have assessed the role of CTCF in CSR mak-
ing use of a conditional mouse model for CTCF depletion in 
mature B cells (CTCFfl/fl; CD19-Creki/+). We previously explored 
the function of CTCF in germinal center B cells using a different 
mouse model (CTCFfl/fl; AID-CreTG/+), which promotes CTCF 
depletion only after B  cell activation and induction of AID 
expression (22). Thus, in the case of CTCFfl/fl; CD19-Creki/+ mice, 
the levels of CTCF are dramatically reduced already in naïve 
B cells (Figure 1E), while in CTCFfl/fl; AID-CreTG/+ mice CTCF 
depletion is delayed and dependent on B cell activation and thus 
naïve B cells have normal CTCF expression (22). Interestingly, 
these mouse models have revealed important functional dif-
ferences upon B  cell activation. CTCFfl/fl; AID-CreTG/+ B  cells 
stimulated in the presence of LPS and IL-4 do not have a 
detectable phenotype, while CTCFfl/fl; CD19-Creki/+ B cells show 
a compromised cell viability and an increase in CSR. This phe-
notype is supported by the finding that under these conditions, 
FigUre 4 | CCCTC-binding factor (CTCF) deletion increases S region somatic mutation and germline transcription. (a) qRT-PCR analysis of activation-induced 
cytidine deaminase (AID) expression in spleen B cells from CTCFfl/+ (n = 7) and CTCFfl/fl (n = 6) mice 48 h after lipopolysaccharide (LPS) + IL-4 stimulation. 
(B) Western blot analysis of AID in B cells from AID−/−, CTCFfl/+, and CTCFfl/fl mice after 48 h of LPS/IL-4 stimulation. Mek2 is shown as a loading control. (c) Analysis 
of AID mutagenic activity by next-generation sequencing (32). DNA was isolated from splenic B cells 48 h after LPS + IL-4 stimulation, amplified by PCR with 
specific primers and analyzed by next-generation sequencing. Graphs show total mutation frequency, mutation frequency at C or G in WRCY/RGYW hotspot motif 
in CTCFfl/+ (n = 3) and CTCFfl/fl (n = 3) mice. p(total) = 0.0039; p(WRCY) = 0.0037; p(RGYW) = 0.0015. (D) Distribution of mutations along the sequenced Sμ region 
in CTCFfl/+ (n = 3) and CTCFfl/fl (n = 3) mice. Mutation frequency at each position is shown. (e) CTCF-binding at the IgH locus in resting and stimulated B cells (data 
from GSE43594).
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the transcriptome of CTCFfl/fl; AID-CreTG/+ B  cells are almost 
intact (22), while LPS/IL-4 stimulated CTCFfl/fl; CD19-Creki/+ 
B cells show drastic transcriptome alterations (our unpublished 
data). Thus, on one hand, these alternative genetic models have 
unveiled distinct contributions of CTCF at early and late stages 
of B cell activation, which will be further investigated. On the 
other hand, the CTCFfl/fl; CD19-Creki/+ model has established 
an important role of CTCF in the regulation of CSR, the focus 
of this study.
We have found here that CTCF depletion in CTCFfl/fl; CD19-
Creki/+ B cells increases the rate of CSR to all isotypes tested, and 
it does so without significantly altering B cell proliferation rate. 
This is an interesting observation because it is a first hint that, 
regardless of the potentially broad functional consequences of 
CTCF depletion, CTCFfl/fl; CD19-Creki/+ B  cells may have an 
intrinsic CSR defect. In search for this defect we first assessed 
AID levels and found that CTCF has not a noticeable role in 
the regulation of AID expression. In contrast, we found that 
the mutation frequency at Sμ is significantly increased in the 
CTCFfl/fl; CD19-Creki/+ B cells, suggesting that the accessibility 
of AID to the switch regions is enhanced in the absence of CTCF. 
In agreement with this hypothesis, we find that B cell activation 
FigUre 5 | CCCTC-binding factor (CTCF) deficiency enhances germline transcription (GLT) in resting B cells. (a,B) qRT-PCR analysis of germline transcript μ (a), 
γ-1 (B) in resting splenic B cells (0 h) or after lipopolysaccharide + IL-4 stimulation from CTCFfl/+ and CTCFfl/fl (n = 3–7). p(0 h, GLTγ1) < 0.0001. (c) qRT-PCR 
analysis of germline transcript γ-3 (left), γ-2b (right) in resting splenic B cells. p(0 h, GLTγ3) = 0.0353; p(0 h, GLTγ2b) = 0.0307. Data are shown as the ΔCt value 
calculated from the difference in the Ct of the GLT and GAPDH. Statistical analysis was done with two-tailed unpaired Student’s t-test.
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results in a redistribution of CTCF-binding along the IgH locus, 
and that GLT is increased in CTCF-deficient naïve B cells.
Although we cannot rule out that CTCF could also restrict CSR 
by the transcriptional silencing of factors, other than AID, impor-
tant to trigger GLT or to process AID-induced lesions, our data 
strongly suggest that CTCF restricts GLT and CSR by its interac-
tion with CBEs found in the IgH locus. In this regard, our findings 
are reminiscent of recent data that made use of a complementary 
approach (29). Specifically, Khamlichi and coworkers generated 
mice with a germline deletion of a DNAseI hypersensitivity site 
along with a CBE (5′hs1R1) and found activation of GLT at vari-
ous S regions in naïve B cells and isotype-specific alterations of 
CSR after B cell activation. These data suggest that 5′hs1R1 con-
tains a CBE acting as a CTCF insulator that precludes premature 
activation of I promoters in S regions (29). Likewise, our data 
strongly suggest that CTCF binds to CBEs at IgH, preventing GLT 
prior to B cell stimulation. Dissecting the contribution of specific 
CBEs and CTCF-mediated chromatin loops to particular CSR 
phenotypic effects is an essential issue remaining. First, it will be 
important to precisely define the CTCF-dependent loops taking 
place before and after B  cell activation by 3C—as previously 
described for CSR synapsis (40). This should be complemented 
with functional analysis performing individual and combined 
deletion of CBEs; this will prove a very challenging task, given the 
complex array of CBEs at the constant region of IgH—including 
at least the 5′hs1R1 CBE and nine CBEs downstream of the 3′RR.
The finding that CTCF depletion promotes increase of GLT in 
resting but not activated B cells is intriguing. We speculate that 
CTCF contributes to establish a chromatin architecture that keeps 
the I promoters silent prior to CSR. Unleashing this architectural 
constraint in naïve B cells by depleting CTCF may facilitate the 
early loading or pre-poising of CSR cofactors that could allow 
faster or better loading of AID and additional CSR components 
at the time of activation. Although this hypothesis would require 
experimental testing, it agrees with previous observations made 
upon depletion of the 5′hs1R1 CBE (29).
In sum, our results are compatible with a model where CTCF 
maintains the IgH locus in a locked architectural conformation 
in naïve B cells that blocks GLT and AID access to S regions, thus 
preventing premature CSR.
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